In the search for new drugs, artificial intelligence in the form of diffusion models is being used in drug design. What ...

In people with Type 1 diabetes (T1D), the immune system shuts down the body's ability to make the hormone insulin, ...

A veteran of Pfizer, Sanofi, and Novo Nordisk who built patient access programmes across West Africa argues that the $500 billion medication adherence crisis plaguing American healthcare has already ...

What's really behind the words is all the hard work put in by all of you.Today's celebration is for the entire College, all ...

Artificial intelligence and predictive analytics are advancing diabetes prevention, diagnosis, and management by integrating data from continuous glucose monitors, electronic health records, and other ...

While some healthcare companies are testing out agentic AI tools, CCS is betting big on the technology as it developed an ...

Recent research underscores AI's growing role in healthcare, from chronic disease management to hospital operations, while exposing gaps in evidence on patient outcomes. Systematic reviews and case ...

This study highlights the potential for using deep learning methods on longitudinal health data from both primary and ...

This study externally validated a machine learning–based model for type 2 diabetes progression (ML-PR) and evaluated its clinical utility in individuals with prediabetes. We included 3,081 ...